This inventor holds 1 USPTO granted patent. Top assignee: Chang Gung University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Po-Jen Chen: Innovator in Pharmaceutical Composition for Disease Treatment
Introduction
Po-Jen Chen is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases mediated by phosphodiesterase 4 (PDE4). His innovative work focuses on the application of Ribociclib, a compound that has shown promise in inhibiting PDE4 activity.
Latest Patents
Po-Jen Chen holds a patent for a pharmaceutical composition that utilizes Ribociclib for treating PDE4-mediated diseases. The patent describes a composition that includes an effective amount of Ribociclib combined with a pharmaceutically acceptable carrier. This invention is particularly advantageous for patients suffering from conditions related to PDE4 activity, providing a new avenue for treatment.
Career Highlights
Po-Jen Chen is affiliated with Chang Gung University, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on patient care and treatment methodologies.
Collaborations
One of his notable collaborators is Tsong-Long Hwang, with whom he has worked on various research projects aimed at enhancing the efficacy of pharmaceutical treatments.
Conclusion
Po-Jen Chen's contributions to the field of pharmaceuticals, particularly through his patent on Ribociclib, highlight his role as an innovator in disease treatment. His work continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile